Dina Andrawess

Special Counsel
Full contact info


Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals

July 14, 2022

Cooley advised ViaCyte, a biotechnology company focused on delivering novel stem cell-derived cell replacement therapies as a functional cure for Type 1 diabetes (T1D), on its definitive agreement to be acquired by global biotechnology company Vertex Pharmaceuticals for $320 million in cash. Partners Rowook Park and Carlos Ramirez, along with associate Lindsey O’Crump, led the Cooley team advising ViaCyte.

Read more

Related contacts

Rowook Park
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Marty Schenker
Senior Counsel , San Francisco
Todd Gluth
Partner, San Diego
Blake Martell
Partner, San Francisco
Charity Williams
Partner, San Diego
Jeffrey Karr
Of Counsel, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Dina Andrawess
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Arman Sagart
Associate, San Diego
Lindsey O'Crump
Associate, Washington, DC
Melissa Meza
Associate, San Diego
Joe Mandry
Associate, San Diego
Julia R. Brinton
Associate, Washington, DC
Kimberley Scimeca
Associate, Boston
Daniel Lac
Associate, San Diego
Amanda Griggs
Associate, New York

Related Practices & Industries

Admissions & credentials